A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis [1]

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 9, 2008, Pages 1102-

  Moulding, Thomas ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSERINE; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ADD ON THERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; CROSS RESISTANCE; DRUG MEGADOSE; DRUG SENSITIVITY; GENETIC RESISTANCE; GENETIC STRAIN; HUMAN; LETTER; MULTIDRUG RESISTANCE; ORGANISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; TUBERCULOSIS; DRUG COMBINATION; MULTIDRUG RESISTANT TUBERCULOSIS; NOTE;

ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; HUMANS; ISONIAZID; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 51149105497     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Katiyar S K, Bihari S, Prakash S, Mamtani M, Kulkarni H. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2008; 12: 139-145.
2. Petty T I, Mitchell R S. Successful treatment of advanced isoniazid- and streptomycin-resistant pulmonary tuberculosis with ethionamide, pyrazinamide, and isoniazid. Am Rev Respir Dis 1962; 86: 503-512.
3. Moulding T S. Should isoniazid be used in retreatment of tubet-culosis despite acquired isoniazid resistance? Am Rev Respir Dis 1981: 123:262-264.
4. Canetti G, Kreis B, Thibier R, Gay P, Le Lirzin M. Current data on primary resistance in pulmonary tuberculosis in adults in France. 2nd survey of the Centre d'Etudes sur la Resistance Primaire: 1965-1966. Rev Tuberc Pneumol (Paris) 1967; 31: 433-474.
5. Morlock G P, Metchock B, Síkes D, Crawford J T, Cooksey R C. Eth A, inb. A, and kat G loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2003; 47: 3799-3805.